METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE Drug Patent Profile
✉ Email this page to a colleague
When do Metoprolol Tartrate And Hydrochlorothiazide patents expire, and when can generic versions of Metoprolol Tartrate And Hydrochlorothiazide launch?
Metoprolol Tartrate And Hydrochlorothiazide is a drug marketed by Alembic, Mylan, and Sun Pharm Inds. and is included in three NDAs.
The generic ingredient in METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; metoprolol tartrate. There are thirty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; metoprolol tartrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE?
- What are the global sales for METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE?
- What is Average Wholesale Price for METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE?
Summary for METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 4 |
Clinical Trials: | 3 |
DailyMed Link: | METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE at DailyMed |
Recent Clinical Trials for METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Mylan Pharmaceuticals | Phase 1 |
Vanderbilt University Medical Center | Phase 1 |
Vanderbilt University | Phase 1 |
See all METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE clinical trials
Pharmacology for METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE
Drug Class | Thiazide Diuretic beta-Adrenergic Blocker |
Mechanism of Action | Adrenergic beta-Antagonists |
Physiological Effect | Increased Diuresis |